×
About 397 results

ALLMedicine™ Primary Prevention of Cardiovascular Disease Center

Research & Reviews  173 results

New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593937
International Journal of Environmental Research and Public Health; Aguilar-Palacio I, Rabanaque MJ et. al.

Oct 23rd, 2020 - The objective of this study was to analyse persistence to lipid-lowering drug use for primary prevention of cardiovascular disease (CVD) in a new users cohort, to explore all-cause and cardiovascular related morbidity, comorbidity and mortality in...

Nutrition and physical activity recommendations from the United States and European car...
https://doi.org/10.1097/HCO.0000000000000763
Current Opinion in Cardiology; Ferraro RA, Fischer NM et. al.

Jul 10th, 2020 - A healthy lifestyle throughout one's lifespan is the core foundation for both primary and secondary prevention of cardiovascular disease (CVD). Risk-based decisions for pharmacological therapy is added on-top of lifestyle management. Thus, underst...

A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk score...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304198
BMC Cardiovascular Disorders; Santos-Ferreira C, Baptista R et. al.

Jun 20th, 2020 - A key strategy for the primary prevention of cardiovascular disease (CVD) is the use of risk prediction algorithms. We aimed to investigate the predictive ability of SCORE (Systematic COronary Risk Estimation) and PCE (Pooled Cohort Equations) sys...

The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A ...
https://doi.org/10.1007/s40266-019-00736-y
Drugs & Aging; Zhou Z, Albarqouni L et. al.

Jan 10th, 2020 - The use of statins in the primary prevention of cardiovascular disease (CVD) is increasing in older adults. Nonetheless, good clinical evidence for the safety and tolerability of statins in this population is limited. We aimed to evaluate the safe...

Low-Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Imp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951082
Journal of the American Heart Association; Fernandez-Jimenez R, Wang TJ et. al.

Dec 11th, 2019 - Background Data are limited on use patterns of low-dose aspirin and its role for primary prevention of cardiovascular disease (CVD) in different racial and ethnic groups. Methods and Results Overall, 65 231 non-Hispanic black and white people aged...

see more →

Guidelines  2 results

Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit–Harm Analysis
https://annals.org/aim/article-abstract/2751452/personalized-prediction-cardiovascular-benefits-bleeding-harms-from-aspirin-primary-prevention

Sep 16th, 2019 - Background: Whether the benefits of aspirin for the primary prevention of cardiovascular disease (CVD) outweigh its bleeding harms in some patients is unclear. Objective: To identify persons without CVD for whom aspirin would probably result in a...

Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabol...
https://doi.org/10.1210/jc.2008-0222
The Journal of Clinical Endocrinology and Metabolism; Rosenzweig JL, Ferrannini E et. al.

Jul 30th, 2008 - The objective was to develop clinical practice guidelines for the primary prevention of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) in patients at metabolic risk. Healthcare providers should incorporate into their practice con...

see more →

Clinicaltrials.gov  199 results

New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593937
International Journal of Environmental Research and Public Health; Aguilar-Palacio I, Rabanaque MJ et. al.

Oct 23rd, 2020 - The objective of this study was to analyse persistence to lipid-lowering drug use for primary prevention of cardiovascular disease (CVD) in a new users cohort, to explore all-cause and cardiovascular related morbidity, comorbidity and mortality in...

Role of Aspirin Explored in Primary Prevention of CVD in Systemic Rheumatic Diseases
https://www.staging.medscape.com/viewarticle/937809

Sep 21st, 2020 - Low-dose aspirin may be considered for the primary prevention of cardiovascular disease (CVD) in patients with autoimmune systemic rheumatic diseases who are at particularly high risk because of their individual cardiovascular risk profile, accord...

Role of Aspirin Explored in Primary Prevention of CVD in Systemic Rheumatic Diseases
https://www.medscape.com/viewarticle/937809

Sep 21st, 2020 - Low-dose aspirin may be considered for the primary prevention of cardiovascular disease (CVD) in patients with autoimmune systemic rheumatic diseases who are at particularly high risk because of their individual cardiovascular risk profile, accord...

Nutrition and physical activity recommendations from the United States and European car...
https://doi.org/10.1097/HCO.0000000000000763
Current Opinion in Cardiology; Ferraro RA, Fischer NM et. al.

Jul 10th, 2020 - A healthy lifestyle throughout one's lifespan is the core foundation for both primary and secondary prevention of cardiovascular disease (CVD). Risk-based decisions for pharmacological therapy is added on-top of lifestyle management. Thus, underst...

A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk score...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304198
BMC Cardiovascular Disorders; Santos-Ferreira C, Baptista R et. al.

Jun 20th, 2020 - A key strategy for the primary prevention of cardiovascular disease (CVD) is the use of risk prediction algorithms. We aimed to investigate the predictive ability of SCORE (Systematic COronary Risk Estimation) and PCE (Pooled Cohort Equations) sys...

see more →

News  23 results

Role of Aspirin Explored in Primary Prevention of CVD in Systemic Rheumatic Diseases
https://www.staging.medscape.com/viewarticle/937809

Sep 21st, 2020 - Low-dose aspirin may be considered for the primary prevention of cardiovascular disease (CVD) in patients with autoimmune systemic rheumatic diseases who are at particularly high risk because of their individual cardiovascular risk profile, accord...

Role of Aspirin Explored in Primary Prevention of CVD in Systemic Rheumatic Diseases
https://www.medscape.com/viewarticle/937809

Sep 21st, 2020 - Low-dose aspirin may be considered for the primary prevention of cardiovascular disease (CVD) in patients with autoimmune systemic rheumatic diseases who are at particularly high risk because of their individual cardiovascular risk profile, accord...

Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit–Harm Analysis
https://annals.org/aim/article-abstract/2751452/personalized-prediction-cardiovascular-benefits-bleeding-harms-from-aspirin-primary-prevention

Sep 16th, 2019 - Background: Whether the benefits of aspirin for the primary prevention of cardiovascular disease (CVD) outweigh its bleeding harms in some patients is unclear. Objective: To identify persons without CVD for whom aspirin would probably result in a...

"It's Not You, It's Me" - Is it Time to Break Up With Aspirin?
https://www.medscape.com/viewarticle/916006_1

Jul 24th, 2019 - This article is republished with permission from the ACC. For more, see www.ACC.org. "It's not you, it's me" is the classic relationship breakup adage used to try to soften the blow of the breakup and indicate that it's not the fault of the person...

"It's Not You, It's Me" - Is it Time to Break Up With Aspirin?
https://www.medscape.com/viewarticle/916006

Jul 24th, 2019 - This article is republished with permission from the ACC. For more, see www.ACC.org. "It's not you, it's me" is the classic relationship breakup adage used to try to soften the blow of the breakup and indicate that it's not the fault of the person...

see more →